Cargando…
Topical phenylbutyrate antagonizes NF-κB signaling and resolves corneal inflammation
Chronic inflammation of the immune privileged cornea originating from viral or nonviral conditions results in significant vision loss. Topical corticosteroids are the common treatments for corneal inflammation, but the drugs cause serious and potentially blinding side effects in the long term. There...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758524/ https://www.ncbi.nlm.nih.gov/pubmed/36536680 http://dx.doi.org/10.1016/j.isci.2022.105682 |